Patient perceptions of anticoagulant treatment with dabigatran or a vitamin K antagonist for stroke prevention in atrial fibrillation according to region and age: an exploratory analysis from the RE-SONANCE study

BACKGROUND: The oral anticoagulant dabigatran offers an effective alternative to vitamin K antagonists (VKAs) for stroke prevention in atrial fibrillation (AF), yet patient preference data are limited. The prospective observational RE-SONANCE study demonstrated that patients with AF, newly initiated...

Descripción completa

Detalles Bibliográficos
Autores principales: Vinereanu, Dragos, Napalkov, Dmitry, Bergler-Klein, Jutta, Benczur, Bela, Ciernik, Martin, Gotcheva, Nina, Medvedchikov, Alexey, Põder, Pentti, Simić, Dragan, Skride, Andris, Tang, Wenbo, Trusz-Gluza, Maria, Vesely, Jiří
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605976/
https://www.ncbi.nlm.nih.gov/pubmed/33929686
http://dx.doi.org/10.1007/s11239-021-02450-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8605976/
https://www.ncbi.nlm.nih.gov/pubmed/33929686
http://dx.doi.org/10.1007/s11239-021-02450-2

Ejemplares similares